Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial

Publication | Open Access

DOI Full Paper Access

Citations

References

2023

Year

Michael Koren, Leyi Lin, Kenneth H. Eckels, Rafael De La Barrera, Vincent Dussupt, Gina Donofrio, Erica L Sondergaard, Kristin T Mills, Merlin L. Robb, Christine Lee,

The Lancet Infectious Diseases

VaccinationVaccine SafetyVaccine DevelopmentJapanese Encephalitis VirusVirus VaccineVaccine EfficacyMedicineVaccine ResearchPhase 1Covid-19